InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-10.9%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by NUSSDORF GLENN H, Director. Officer active across 1 company, notably Organogenesis Holdings Inc.. Cumulatively, 6 filings have been recorded. Split: 2 buys · 2 sells. Total volume traded: €105m. History available since 6 May 2021. The latest transaction was disclosed on 18 November 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
25,000 shares@ US$9.930.033% mcap0.2% of flowClass A Common StockSEC:0001062993-21-011406:0
Ideal exit: 15 Aug 2022 (T+270)
25,000 shares@ US$9.930.033% mcap0.4% of flowClass A Common StockSEC:0001062993-21-011406
Ideal exit: 15 Aug 2022 (T+270)
3,887,500 shares@ US$16.407.95% mcap49.8% of flowClass A Common StockSEC:0001661181-21-000050:0
3,887,500 shares@ US$16.4049.8% of flowClass A Common StockSEC:0001661181-21-000050
23,855,148 shares0Class A Common StockSEC:0001661181-21-000040
23,855,148 shares0Class A Common StockSEC:0001661181-21-000040:0
6 of 6 declarations
About NUSSDORF GLENN H
Glenn H. Nussdorf is a Board Member at Organogenesis Holdings Inc. He plays a key role in the governance and strategy of the company. Nussdorf brings his experience in management and operations to the board. His commitment to efficiency and innovation is essential for the development of Organogenesis.
